SOUTHERN ACIDS (M) |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.38 MYR | -0.59% |
|
-0.59% | +7.30% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.18B 249M | Sales 2023 | 1.11B 234M | Capitalization | 493M 104M |
|---|---|---|---|---|---|
| Net income 2022 | 94M 19.85M | Net income 2023 | 33M 6.97M | EV / Sales 2022 | 0.19 x |
| Net cash position 2022 | 297M 62.7M | Net cash position 2023 | 379M 79.93M | EV / Sales 2023 | 0.1 x |
| P/E ratio 2022 |
5.58
x | P/E ratio 2023 |
14.8
x | Employees | 1,737 |
| Yield 2022 |
1.3% | Yield 2023 |
1.39% | Free-Float | 25.53% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.59% | ||
| 1 week | -0.59% | ||
| Current month | +0.90% | ||
| 1 month | -0.59% | ||
| 3 months | +5.96% | ||
| 6 months | +4.97% | ||
| Current year | +7.30% |
1 week
3.38
3.41
1 month
3.163.50
Current year
3.153.50
1 year
3.123.65
3 years
3.124.30
5 years
2.704.30
10 years
2.705.82
| Managers | Title | Age | Since |
|---|---|---|---|
Kok Thye Low
CEO | Chief Executive Officer | 45 | - |
Kee Yoong Cheong
DFI | Director of Finance/CFO | 56 | 13-09-30 |
Fu Khate Lai
CTO | Chief Tech/Sci/R&D Officer | 36 | 14-07-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kim Long Lim
BRD | Director/Board Member | 64 | - |
Kin Mun Chung
BRD | Director/Board Member | 57 | 12-03-19 |
Kee Yoong Cheong
DFI | Director of Finance/CFO | 56 | 13-09-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 3.38 | -0.59% | 2 500 |
| 24-05-06 | 3.4 | 0.00% | 11,300 |
| 24-05-02 | 3.4 | +1.49% | 3,000 |
| 24-04-30 | 3.35 | -1.47% | 8,000 |
End-of-day quote BURSA MALAYSIA, May 06, 2024
More quotes
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products. The Company operates through three segments: Oleochemical, Milling & Estate, and Healthcare. The Oleochemical segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The manufacturing plant is located in Kapar, Klang, which has an annual manufacturing capacity of approximately 100,000 metric tons (MT). The Milling & Estate Segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (POM) and palm kernel, as well as oil palm cultivation. It operates two POM located in Riau, Indonesia with a combined milling capacity of 100 MT per hour. The Healthcare Segment operates Sri Kota Specialist Medical Centre (Sri Kota), a 232-bedded private tertiary hospital located in Klang, Selangor.
Sector
Commodity Chemicals
Calendar
2024-05-23
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.30% | 98.23M | |
| +4.46% | 102B | |
| -3.35% | 65.27B | |
| +46.67% | 41.44B | |
| +19.71% | 40.05B | |
| +6.40% | 32.48B | |
| +12.57% | 19.71B | |
| +17.06% | 17.33B | |
| +20.73% | 15.6B | |
| +11.69% | 15.34B |
- Stock Market
- Equities
- SAB Stock